Trial · NCT07436611
Registered outcomes16
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 16 of 16
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Clinic Objective improvement rating at week 12 | From before laser treatment to the end of treatment after 12 weeks of cream application | The average percentage improvement (0-100% with higher scores being a better outcome) of port wine stain appearance in the cream treated area from baseline to week 12, or at last visit if early withdrawal/discontinuation occurs, as assessed by the principal investigator during the clinic visit. |
| Secondary | Subjective improvement rating (all timepoints) | From before laser treatment to the end of treatment after 12 weeks of cream application | Subjective (patient or parent/caregiver) improvement rating (0-100% with higher scores being a better outcome) of port wine stain from baseline after 0, 4, 8 and 12 weeks of treatment. |
| Secondary | Clinic Objective improvement rating (all timepoints) | From before laser treatment to the end of treatment after 12 weeks of cream application | Clinic Objective (investigator) improvement rating (0-100% with higher scores being a better outcome) in port wine stain from baseline after 0, 4, 8 and 12 weeks of treatment |
| Secondary | Photographic Objective improvement rating (all timepoints) | From before laser treatment to the end of treatment after 12 weeks of cream application | Photographic Objective improvement rating (0-100% with higher scores being a better outcome), assessed by a committee of three dermatologists, in port wine stain from baseline after 0, 4, 8 and 12 weeks of treatment |
| Other | Subjective improvement rating change at follow-up | From before laser treatment to follow-up visit (16 weeks) | Subjective (patient or parent/caregiver) improvement rating (0-100% with higher scores being a better outcome) change of cream treated area from baseline at follow-up visit |
| Other | Subjective improvement rating (post-treatment) | 4 weeks between end of treatment and follow-up visit | Subjective (patient or parent/caregiver) improvement rating (0-100% with higher scores being a better outcome) change of cream treated area between week 12 and follow-up |
| Other | Clinic Objective improvement rating change at follow-up | From before laser treatment to follow-up visit (16 weeks) | Clinic Objective (investigator) improvement rating (0-100% with higher scores being a better outcome) change of cream treated area from baseline at follow-up visit |
| Other | Clinic Objective improvement rating (post-treatment) | 4 weeks between end of treatment and follow-up visit | Clinic Objective (investigator) improvement rating (0-100% with higher scores being a better outcome) change of cream treated area between week 12 and follow-up |
| Other | Photographic Objective improvement rating change at follow-up | From before laser treatment to follow-up visit (16 weeks) | Photographic Objective improvement rating (0-100% with higher scores being a better outcome), assessed by a committee of three dermatologists, change of cream treated area from baseline at follow-up visit |
| Other | Photographic Objective improvement rating (post-treatment) | 4 weeks between end of treatment and follow-up visit | Photographic Objective improvement rating (0-100% with higher scores being a better outcome), assessed by a committee of three dermatologists, change of cream treated area between week 12 and follow-up |
| Other | Categorical Improvement of port wine stain | From before laser treatment to the end of treatment after 12 weeks of cream application | Categorical Improvement (5-point scale with higher scores being a better outcome) of port wine stain in cream treated area from baseline after 12 weeks of treatment. |
| Other | Colorimetry rating (all timepoints) | From before laser treatment to the follow-up visit (16 weeks) | Change in extent and intensity of port wine stain colour of the cream treated area from baseline at weeks 0, 4, 8, 12 and follow-up/last assessment, measured using a colorimetry system through standardized clinical photographs |
| Other | Colorimetry intra-patient rating | From before laser treatment to the follow-up visit (16 weeks) | Difference in extent and intensity of port wine stain colour between the two treatment areas (laser+cream or laser only) of each individual at each assessment (pre-laser baseline, weeks 0, 4, 8, 12 and follow-up/last assessment) using the colorimetry system |
| Other | Subjective intra-patient rating | From start of cream treatment to the follow-up visit (16 weeks) | Difference in subjective (patient or parent/caregiver) improvement rating (0-100% with higher scores being a better outcome) of port wine stain between the treatment areas (laser+cream or laser only) of each individual at each assessment (week 0, 4, 8, 12 and follow-up/last assessment) |
| Other | Clinic Objective intra-patient rating | From start of cream treatment to the follow-up visit (16 weeks) | Difference in clinic objective (investigator) improvement rating (0-100% with higher scores being a better outcome) of port wine stain between the treatment areas (laser+cream or laser only) of each individual at each assessment (week 0, 4, 8, 12 and follow-up/last assessment) |
| Other | Photographic Objective intra-patient rating | From start of cream treatment to the follow-up visit (16 weeks) | Difference in photographic objective (committee) improvement rating (0-100% with higher scores being a better outcome) of port wine stain between the treatment areas (laser+cream or laser only) of each individual at each assessment (week 0, 4, 8, 12 and follow-up/last assessment) |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT07436611/registered